Aldesleukin Completed Phase 1 Trials for Neuroblastomas Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00006480Biological Therapy and Gene Therapy in Treating Children With Recurrent or Refractory Neuroblastoma